Comparative molecular field analysis study of stilbene derivatives active against A549 lung carcinoma

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 5, 2003, Pages 516-521

  Kim, Sanghee ^a   Min, Sun Young ^b   Lee, Sang Kook ^c   Cho, Won Jea ^b  

^a Seoul National University   (South Korea)

^b Chonnam National University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

A 549; Combretastatin; Comparative molecular field analysis (coMFA); Cytotoxicity; Stilbene

Indexed keywords

1 (2 FURANYL) 2 (3,4,5 TRIMETHOXYPHENYL)ETHENE; 1 (3 FURANYL) 2 (3,4,5 TRIMETHOXYPHENYL)ETHENE; 1 (3 PYRIDYL) 2 (3,4,5 TRIMETHOXYPHENYL)ETHANE; 1 (3 PYRIDYL) 2 (3,4,5 TRIMETHOXYPHENYL)ETHENE; 1 (3 THIOPHENYL) 2 (3,4,5 TRIMETHOXYPHENYL)ETHENE; 1 (4 PYRIDYL) 2 (3,4,5 TRIMETHOXYPHENYL)ETHENE; ANTINEOPLASTIC AGENT; COMBRETASTATIN; COMBRETASTATIN A1; PROTEIN INHIBITOR; RESVERATROL; STILBENE DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG; HETEROCYCLIC COMPOUND;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL LINE; COMPARATIVE MOLECULAR FIELD ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG CONFORMATION; DRUG SYNTHESIS; ENERGY; GRAPE; HUMAN; HUMAN CELL; LUNG CARCINOMA; MICROTUBULE ASSEMBLY; MOLECULAR DYNAMICS; MOLECULAR MODEL; QUANTITATIVE ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VALIDATION PROCESS; X RAY CRYSTALLOGRAPHY; ALGORITHM; CARCINOMA; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; CONFORMATION; DRUG EFFECT; LUNG TUMOR; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; HETEROCYCLIC COMPOUNDS; HUMANS; LUNG NEOPLASMS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STILBENES;

EID: 0642340666     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.516     Document Type: Article

References (22)

1. Pettit G. R., Singh S. B., Hamel E., Lin C. M., Alberts D. S., Garcia-Kendal D., Experientia, 45, 209-211 (1989).
2. Bai R., Pettit G. R., Hamel E., Biochem. Pharmacol., 39, 1941-1949 (1990).
3. Ferrigni N. R., McLaughlin J. L., Powell R. G., Smith C. R., J. Nat. Prod., 47, 347-352 (1984).
4. Gill M. T., Bajaj R., Chang C. J., Nichols D. E., McLaughlin J. L., J. Nat. Prod., 50, 36-40 (1987).
5. Lin C. M., Singh S. B., Chu P. S., Dempcy R. O., Schmidt J. M., Pettit G. R., Hamel E., Mol. Pharmacol., 34, 200-208 (1988).
6. McGown A. T., Fox B. W., Cancer Chemother. Pharmacol., 26, 79-81 (1990).
7. Jordan A., Hadfield J. A., Lawrence N. J., McGown A. T., Med. Res. Rev., 18, 259-296 (1998).
8. Ter Haar E., Rosenkranz H. S., Hamel E., Day B. W., Bioorg. Med. Chem., 4, 1659-1671 (1996).
9. Nandy P., Banerjee S., Gao H., Hui M. B., Lien E., J. Pharmaceutical. Res., 8, 776-781 (1991).
10. Brown M. L., Rieger J. M., Macdonald T. L., Bioorg. Med. Chem., 8, 1433-1441 (2000).
11. Kim S., Ko H., Park J. E., Jung S., Lee S. K., Chun Y.-J., J. Med. Chem., 45, 160-164 (2002).
12. Cramer R. D. III, Patterson D. E., Bunce J. D., J. Am. Chem. Soc., 110, 5959-5967 (1988).
13. Raghavan K., Buolamwini J. K., Fesen M. R., Pommier Y., Kohn K. W., Weinstein J. N., J. Med. Chem., 38, 890-897 (1995).
14. Rubinstein L. V., Shoemaker R. H., Paull K. D., Simon R. M., Tosini S., Skehan P., Scudiero D. A., Monks A., Boyd M. R., J. Natl. Cancer Inst., 82, 1113-1118 (1990).
15. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., Boyd M. R., J. Natl. Cancer Inst., 82, 1107-1112 (1990).
16. Alley M. C., Scudiero D. A., Monks A., Hursey M. L., Czerwinski M. J., Fine D. L., Abbott B. J., Mayo J. G., Shoemaker R. H., Boyd M. R., Cancer Res., 48, 589-601 (1988).
17. Mossman T., J. Immunol. Meth., 65, 55-63 (1983).
18. Wu F. Y. H., Liao W. C., Chang H. M., Life Sci., 52, 1797-1804 (1993).
19. The Sybyl program (Version 6.3) was supplied by Tripos Associates, 1699 South Hanley Road, Suite 303, St. Louis, Missouri 63144, U.S.A.
20. Pettit G. R., Singh S. B., Niven M. L., Hamel E., Schmidt J. M., J. Nat. Prod., 50, 119-131 (1987).
21. Cushman M., Nagarathnam D., Gopal D., He H.-M., Lin C. M., Hamel E., J. Med. Chem., 35, 2293-2306 (1992).
22. Cushman M., Nagarathnam D., Gopal D., Chakraborti A. K., Lin C. M., Hamel E., J. Med. Chem., 34, 2579-2588 (1991).